首页> 外文期刊>Revista Brasileira de Anestesiologia >Comparison of the effects of sugammadex and neostigmine on postoperative nausea and vomiting a??
【24h】

Comparison of the effects of sugammadex and neostigmine on postoperative nausea and vomiting a??

机译:Sugammadex和新斯的明对术后恶心和呕吐的作用的比较

获取原文
           

摘要

Background and objectives: The aim of our study is to compare the effects of sugammadex and neostigmine, used for neuromuscular blockage antagonism, on postoperative nausea and vomiting (PONV). Methods: Our study was completed with 98 ASA I-II risk patients undergoing endotracheal intubation under general anesthesia. At the end of the surgery patients were randomly divided into two groups given 2 mg kg -1 sugammadex (Group S) or 50 ?μg kg -1 neostigmine plus 0.2 mg kg -1 atropine (Group N). Monitoring and recording times were set as 1 hour postoperative and from 1-6, 6-12, and 12-24 hours. The anti-emetic amounts administered were recorded. Results: In the first hour postoperative 13 patients in Group N (27%) and 4 in Group S (8%) were observed to have nausea and/or vomiting and the difference was statistically significant ( p = 0.0016). During the 24 hours of monitoring there was no significant difference in the incidence and severity of PONV ( p > 0.05), however the number of patients given ondansetron for PONV treatment in Group N was statistically significantly higher than the number in Group S (16 in Group N, 6 in Group S, p < 0.011). Conclusions: At the end of our study comparing neostigmine with sugammadex for neuromuscular blockage antagonism, we found use of sugammadex had lower incidence of PONV in the postoperative 1st hour and less anti-emetic use in 24 hours of monitoring.
机译:背景与目的:我们的研究目的是比较用于神经肌肉阻滞拮抗作用的舒美糊精和新斯的明对术后恶心和呕吐(PONV)的作用。方法:我们的研究完成了98例在全身麻醉下接受气管插管的ASA I-II风险患者。手术结束后,将患者随机分为两组,分别给予2 mg kg -1 sugammadex(S组)或50μgkg -1的新斯的明胺加0.2 mg kg -1的阿托品(N组)。监测和记录时间设置为术后1小时以及1-6、6-12和12-24小时。记录给药的止吐药量。结果:术后第一小时,N组13例(27%)和S组4例(8%)出现恶心和/或呕吐,差异具有统计学意义(p = 0.0016)。在监测的24小时内,PONV的发生率和严重程度无显着差异(p> 0.05),但是N组接受恩丹西酮进行PONV治疗的患者人数在统计学上显着高于S组(16人为N组,S组中的6,p <0.011)。结论:在我们的研究将新斯的明与舒马地葡糖进行神经肌肉阻滞拮抗作用的比较结束时,我们发现在监测的第一小时使用舒马地葡糖具有较低的PONV发生率,而在监测的24小时内使用止吐药较少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号